Promising research on the use of palbociclib in the treatment of breast cancer

Role of genomics in assessing risk, especially in ovarian cancer

The relationship between obesity and cancer, and other dietary factors

New antibody-drug conjugate shows early promise against all forms of melanoma

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib

The global control and prevention of cervical cancer caused by HPV

Implications for breast cancer treatment in those who are obese or diabetic.

EBCC 2014 key messages to doctors

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer

Biomarker development for ipilimumab and prostate GVAX treatment

mCRPC management in Taiwan - expert interview

The future of mCRPC treatment - expert discussion